Company Filing History:
Years Active: 2022-2025
Title: Philip Radford: Innovator in Patient Sample Tracking
Introduction
Philip Radford is an accomplished inventor based in Wake Forest, North Carolina, recognized for his contributions to medical technology. With two patents to his name, he has made significant strides in the area of patient sample tracking systems.
Latest Patents
Radford's latest inventions include a "Patient Sample Tracking System and Methods" and a "Label for Medical Specimen Tracking." The first patent offers a comprehensive system for collecting and tracking samples for testing. This innovative kit features a housing designed to store a sample securely, along with a label that can adhere to the housing. The label is engineered with images oriented both horizontally and vertically, ensuring the same readable context is available for scanning. This design strategically positions the images so that variations in label placement or reader orientation have minimal impact on readability.
The second patent focuses on a dedicated label for medical specimen tracking, further enhancing the efficiency and accuracy of sample management in clinical settings.
Career Highlights
Philip Radford is currently employed at Radeas, LLC, where he utilizes his expertise to advance healthcare technologies. His work plays a crucial role in improving patient care and streamlining laboratory processes.
Collaborations
Throughout his career, Radford has collaborated with notable professionals, including Matthew James Wright and Matthew Wright. These partnerships have facilitated the development of innovative solutions in the medical field, contributing to the success of their projects.
Conclusion
As an inventor, Philip Radford continues to push the boundaries of innovation in patient sample tracking. His patents not only reflect his creativity but also his commitment to improving healthcare processes. Through his work at Radeas, LLC, Radford is making a significant impact on the efficiency of medical testing, leading to better patient outcomes.